Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
FBIOthis companyFortress Biotech, Inc.	$1.96	-54.3×	2.05×	1.61×	-4.81×	-588.7%	66.9%	-111.0%	10.8%	13.7%	-50.0%	-64.4%	1.49×	0.25×	-8.06×	2.49×	0.7%	6	0.11	4	A
CRVOCervoMed Inc.	$1.41	-2.65×	3.92×	0×	-2.34×	-51.0%	0.0%	0.0%	0.0%	-148.0%	-151.0%	-32.8%	0×	0.31×	0×	4.84×	0.0%	2	-3.92	2	C
GANXGain Therapeutics, Inc.	$1.07	-5.28×	5.72×	0×	-4.48×	-46.1%	0.0%	0.0%	0.0%	-108.6%	-95.0%	-17.4%	0.04×	1.05×	0×	6.63×	0.0%	3	-6.34	2	C
IMUXImmunic, Inc.	$8.02	-0.86×	-12.46×	0×	-0.7×	-91.8%	0.0%	0.0%	0.0%	1456.2%	1693.4%	-103.4%	-0.1×	0.15×	0×	0.75×	0.0%	2	-5.39	2	C
NTRBNutriband Inc.	$5.70	-1.86×	8.35×	27.38×	-6.42×	-123.8%	27.8%	-408.4%	-404.1%	-123.2%	-120.1%	-9.2%	0.04×	0.54×	-369.11×	6.36×	0.0%	3	34.78	1	C-
PMVPPMV Pharmaceuticals, Inc.	$1.28	-0.84×	0.63×	0×	-0.36×	-52.3%	0.0%	0.0%	0.0%	-74.2%	-79.5%	-112.1%	0.01×	0.47×	0×	10.09×	0.0%	1	-6.12	3	B-
Peer median	—	-1.86×	3.92×	0×	-2.34×	-52.3%	0.0%	0.0%	0.0%	-108.6%	-95.0%	-32.8%	0.01×	0.47×	0×	6.36×	0.0%	2	-5.39	2	—